Chemours Co·4

Mar 5, 8:46 PM ET

Martinko Joseph T. 4

4 · Chemours Co · Filed Mar 5, 2025

Insider Transaction Report

Form 4
Period: 2025-03-03
Transactions
  • Award

    Common Stock

    2025-03-03+13,43728,088.146 total
  • Award

    Stock Option (Right to Buy)

    2025-03-03+44,66444,664 total
    Exercise: $13.86Exp: 2035-03-03Common Stock (44,664 underlying)
  • Award

    Stock Option (Right to Buy)

    2025-03-03+46,45146,451 total
    Exercise: $15.25Exp: 2035-03-03Common Stock (46,451 underlying)
Footnotes (4)
  • [F1]Restricted Stock Unit ("RSU") award scheduled to vest in three equal annual installments beginning on March 1, 2026.
  • [F2]Includes directly owned shares, RSUs and dividend equivalent units.
  • [F3]These options are scheduled to vest in three equal annual installments beginning on March 3, 2026.
  • [F4]Represents a 10 percent premium above the closing price of the Company common stock on the date of grant.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES